149 related articles for article (PubMed ID: 37270436)
1. Surgery on Metastatic Foci is a Better Strategy for Stage IV Breast Cancer Patients with only Nonregional Lymph Node Metastasis.
Jiao Y; Guo X; Wu H; Lv Q
Adv Ther; 2023 Jul; 40(7):3247-3262. PubMed ID: 37270436
[TBL] [Abstract][Full Text] [Related]
2. Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis.
Jiao Y; Guo X; Lv Q
Breast Cancer; 2023 Jul; 30(4):647-656. PubMed ID: 37103742
[TBL] [Abstract][Full Text] [Related]
3. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
Ali A; Hoyle A; Mistry H; Clarke NW
BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis.
Wu SG; Li FY; Chen Y; Sun JY; Lin HX; Lin Q; He ZY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):467-474. PubMed ID: 27812853
[TBL] [Abstract][Full Text] [Related]
5. Influence of nonregional lymph node metastasis as a prognostic factor in metastatic prostate cancer patients.
Cho S; Kang SG; Tae BS; Cheon J
Korean J Urol; 2012 Oct; 53(10):673-9. PubMed ID: 23136626
[TBL] [Abstract][Full Text] [Related]
6. A novel nomogram and risk classification system for predicting lymph node metastasis of breast mucinous carcinoma: A SEER-based study.
Wu SL; Gai JD; Yu XM; Mao X; Jin F
Cancer Med; 2022 Dec; 11(24):4767-4783. PubMed ID: 35599552
[TBL] [Abstract][Full Text] [Related]
7. The role of surgery on locoregional treatment of patients with breast cancer newly diagnosed with ipsilateral supraclavicular lymph node metastasis.
Liu BW; Chen LX; Ma K; Chi JR; Yang ZJ; Yu Y; Cao XC
J Cancer Res Ther; 2022 Apr; 18(2):496-502. PubMed ID: 35645120
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
9. The inconsistency of molecular subtypes between primary foci and metastatic axillary lymph nodes in Luminal A breast cancer patients among Chinese women, an indication for chemotherapy?
Sun Y; Liu X; Cui S; Li L; Tian P; Liu S; Li Y; Yin M; Zhang C; Mao Q; Wang J
Tumour Biol; 2016 Jul; 37(7):9555-63. PubMed ID: 26790445
[TBL] [Abstract][Full Text] [Related]
10. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
11. Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer.
Heesterman BL; van der Poel HG; Schoots IG; Mehra N; Aben KKH
BJU Int; 2022 Aug; 130(2):217-225. PubMed ID: 34741789
[TBL] [Abstract][Full Text] [Related]
12. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
13. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
14. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
[TBL] [Abstract][Full Text] [Related]
15. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
16. Lymph Nodes Dissection in Elderly Patients with T3-T4 Laryngeal Cancer.
Pan Y; Zhao X; Zhao D; Liu J
Clin Interv Aging; 2020; 15():2321-2330. PubMed ID: 33324044
[TBL] [Abstract][Full Text] [Related]
17. The importance of extracapsular extension of axillary lymph node metastases in breast cancer.
Ilknur GB; Hilmi A; Tülay C; Oguz C; Selma S; Serdar S; Uğur Y; Pinar B; Omer H; Münir K;
Tumori; 2004; 90(1):107-11. PubMed ID: 15143982
[TBL] [Abstract][Full Text] [Related]
18. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
19. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis.
Chung SH; de Geus SWL; Shewmaker G; Romatoski KS; Drake FT; Ko NY; Merrill AL; Hirsch AE; Tseng JF; Sachs TE; Cassidy MR
Ann Surg Oncol; 2023 Sep; 30(9):5610-5618. PubMed ID: 37204557
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival outcomes between axillary conservation and axillary lymph node dissections in N1 early breast cancer: a propensity-matched SEER analysis.
Wu N; Su X; Tan Q; Luo J; Yuan Y; Hou L; Li J
Clin Transl Oncol; 2023 Apr; 25(4):1091-1101. PubMed ID: 36515887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
